Dynamics in Post-pandemic Global Adalimumab Industry: Supply and Demand, Markets and Prices 2021-2027
Report Code: KNJ669204
Publisher: Date of Publish:
No. of Pages: 133 Category: Pharmaceuticals and Healthcare Publisher: Date of Publish:
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Adalimumab market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Adalimumab market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category Adalimumab Adalimumab Biosimilar Segmented by End User/Segment Adults Children Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Sandoz Mylan Boehringer Ingelheim Biogen Amgen AbbVie
Table of Contents 1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Adalimumab Market Status and Forecast (2016-2027) 1.3.2 Global Adalimumab Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis 2 Global Adalimumab Supply by Company 2.1 Global Adalimumab Sales Volume by Company 2.2 Global Adalimumab Sales Value by Company 2.3 Global Adalimumab Price by Company 2.4 Adalimumab Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate 3 Global and Regional Adalimumab Market Status by Category 3.1 Adalimumab Category Introduction 3.1.1 Adalimumab 3.1.2 Adalimumab Biosimilar 3.2 Global Adalimumab Market by Category 3.2.1 Global Adalimumab Sales Volume by Category (2016-2021) 3.2.2 Global Adalimumab Sales Value by Category (2016-2021) 3.2.3 Global Adalimumab Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category 4 Global and Regional Adalimumab Market Status by End User/Segment 4.1 Adalimumab Segment by End User/Segment 4.1.1 Adults 4.1.2 Children 4.2 Global Adalimumab Market by End User/Segment 4.2.1 Global Adalimumab Sales Volume by End User/Segment (2016-2021) 4.2.2 Global Adalimumab Sales Value by End User/Segment (2016-2021) 4.2.3 Global Adalimumab Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment 5 Global Adalimumab Market Status by Region 5.1 Global Adalimumab Market by Region 5.1.1 Global Adalimumab Sales Volume by Region 5.1.2 Global Adalimumab Sales Value by Region 5.2 North America Adalimumab Market Status 5.3 Europe Adalimumab Market Status 5.4 Asia Pacific Adalimumab Market Status 5.5 Central & South America Adalimumab Market Status 5.6 Middle East & Africa Adalimumab Market Status 6 North America Adalimumab Market Status 6.1 North America Adalimumab Market by Country 6.1.1 North America Adalimumab Sales Volume by Country (2016-2021) 6.1.2 North America Adalimumab Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico 7 Europe Adalimumab Market Status 7.1 Europe Adalimumab Market by Country 7.1.1 Europe Adalimumab Sales Volume by Country (2016-2021) 7.1.2 Europe Adalimumab Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain 8 Asia Pacific Adalimumab Market Status 8.1 Asia Pacific Adalimumab Market by Country 8.1.1 Asia Pacific Adalimumab Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific Adalimumab Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia 9 Central & South America Adalimumab Market Status 9.1 Central & South America Adalimumab Market by Country 9.1.1 Central & South America Adalimumab Sales Volume by Country (2016-2021) 9.1.2 Central & South America Adalimumab Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia 10 Middle East & Africa Adalimumab Market Status 10.1 Middle East & Africa Adalimumab Market by Country 10.1.1 Middle East & Africa Adalimumab Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa Adalimumab Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia 11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 Adalimumab Manufacturing Cost Analysis 11.5 Adalimumab Sales Channel and Distributors Analysis 11.5.1 Adalimumab Sales Channel 11.5.2 Adalimumab Distributors 11.6 Adalimumab Downstream Major Buyers 12 Global Adalimumab Market Forecast by Category and by End User/Segment 12.1 Global Adalimumab Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global Adalimumab Forecast by Category 12.2.1 Global Adalimumab Sales Volume Forecast by Category 12.2.2 Global Adalimumab Sales Value Forecast by Category 12.2.3 Global Adalimumab Price Forecast by Category 12.3 Global Adalimumab Forecast by End User/Segment 12.3.1 Global Adalimumab Sales Volume Forecast by End User/Segment 12.3.2 Global Adalimumab Sales Value Forecast by End User/Segment 12.3.3 Global Adalimumab Price Forecast by End User/Segment 13 Global Adalimumab Market Forecast by Region/Country 13.1 Global Adalimumab Market Forecast by Region (2022-2027) 13.1.1 Global Adalimumab Sales Volume Forecast by Region (2022-2027) 13.1.2 Global Adalimumab Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast 14 Key Participants Company Information 14.1 Sandoz 14.1.1 Company Information 14.1.2 Adalimumab Product Introduction 14.1.3 Sandoz Adalimumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 Mylan 14.2.1 Company Information 14.2.2 Adalimumab Product Introduction 14.2.3 Mylan Adalimumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 Boehringer Ingelheim 14.3.1 Company Information 14.3.2 Adalimumab Product Introduction 14.3.3 Boehringer Ingelheim Adalimumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Biogen 14.4.1 Company Information 14.4.2 Adalimumab Product Introduction 14.4.3 Biogen Adalimumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Amgen 14.5.1 Company Information 14.5.2 Adalimumab Product Introduction 14.5.3 Amgen Adalimumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis 14.6 AbbVie 14.6.1 Company Information 14.6.2 Adalimumab Product Introduction 14.6.3 AbbVie Adalimumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.6.4 SWOT Analysis ... 15 Conclusion 16 Methodology
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com